Incisional hernia repair with plication and utilization of Botox injections: First case report from Saudi Arabia for a 19‐year‐old female

Hijji, Talal; AlShammari, Abdullah; Alhammad, AlAnoud K; AlKhalefah, Ghadah; Hashem, Fuad; Almomen, Salha; Aburahmah, Mohammad

doi:10.1002/ccr3.1984

Cited by 3 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Protocols varied on the number of injection sites and dosage of BTA. Ten studies reported using 3 injection sites on each side of the abdomen, 5,7–15 and 5 studies reported using 5 injection sites on each side of the abdomen 16–20 . One study reported using between 3 and 5 injection sites on each side of the abdomen 21 .…”

Section: Resultsmentioning

confidence: 99%

“…One study reported using between 3 and 5 injection sites on each side of the abdomen 21 . Four studies injected a total of 200 U of BTA 5,10,11,14 ; 7 studies injected 300 U of BTA 7–9,12,13,15,21 ; and 5 studies injected 500 U of BTA 16–18 . These dosages were diluted into 0.9% saline and divided into 6 5,7–15 or 10 16–20 aliquots based on the number of injection sites.…”

Section: Resultsmentioning

confidence: 99%

“…Four studies injected a total of 200 U of BTA 5,10,11,14 ; 7 studies injected 300 U of BTA 7–9,12,13,15,21 ; and 5 studies injected 500 U of BTA 16–18 . These dosages were diluted into 0.9% saline and divided into 6 5,7–15 or 10 16–20 aliquots based on the number of injection sites. All 16 included studies used ultrasound guidance when performing injections to identify the layers of the abdominal wall musculature.…”

Section: Resultsmentioning

confidence: 99%

“…Five studies additionally used electromyographic guidance to identify locations of maximal muscle activity 16–20 . Two studies elected to spare the transverse abdominis and injected BTA into only the external and internal obliques, 10,11 whereas 12 injected all 3 layers 5,7–9,11–18,21 . One study injected BTA into the space between the internal and external obliques 20 .…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Ultrasound‐Guided Lateral Abdominal Wall Botulinum Toxin Injection Before Ventral Hernia Repair

Kurumety

Walker

Samet

et al. 2020

J of Ultrasound Medicine

View full text Add to dashboard Cite

Preoperative ultrasound‐guided lateral abdominal wall botulinum toxin injection is a promising method for improving patient outcomes and reducing recurrence rates after ventral hernia repair. A review of the literature demonstrates variability in the procedural technique, without current standardization of protocols. As radiologists may be increasingly asked to perform ultrasound‐guided botulinum toxin injections of the lateral abdominal wall, familiarity with the procedure and current literature is necessary.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Ultrasound‐Guided Lateral Abdominal Wall Botulinum Toxin Injection Before Ventral Hernia Repair

Kurumety

Walker

Samet

et al. 2020

J of Ultrasound Medicine

View full text Add to dashboard Cite

show abstract

Is there a role for botulinum toxin A in the emergency setting for delayed abdominal wall closure in the management of the open abdomen? A systematic review

Luton

Mortimer

Hopkins

et al. 2023

annals

View full text Add to dashboard Cite

Introduction Emergency laparotomy for either trauma or non-trauma indications is common and management is varied. Use of the open abdomen technique allowing for planned re-look is an option; however, performing delayed definitive fascial closure (DFC) following this can be a challenge. The use of botulinum toxin-A (BTX) infiltration into the lateral abdominal wall has been well documented within the elective setting; its use within the emergency setting is undecided. This systematic review assesses the efficacy and safety of BTX injection into the lateral abdominal wall muscles in the emergency setting. The primary outcome is DFC rate. Methods Systematic review was performed according to the PROSPERO registered protocol (CRD42020205130). Papers were dual screened for eligibility, and included if they met pre-stated criteria where the primary outcome was DFC. Articles reporting fewer than five cases were excluded. Bias was assessed using the Cochrane Risk of Bias and Joanna Brigg’s appraisal tools. Findings Fourteen studies were screened for eligibility, twelve full texts were reviewed and two studies were included. Both studies showed evidence of bias due to confounding factors and lack of reporting. Both studies suggested significantly higher rates of DFC than reported in the literature against standard technique (90.7% vs 66%); however, these data are difficult to interpret due to strict study inclusion criteria or lack of a control population. Conclusion The use of BTX is deemed safe and its effects in the emergency situation may have great potential. Unfortunately, to date, there is insufficient evidence to facilitate opinion.

show abstract

Preoperative Botulinum Toxin Injection for Complex Abdominal Wall Hernia Repair

Almutairi,

Almat’hami,

Al Ahmari

et al. 2023

ejmhr

View full text Add to dashboard Cite

Introduction: Due to their higher rates of morbidity and recurrence, complex abdominal wall hernias provide a difficult clinical dilemma. Botulinum toxin injection has been suggested as a feasible treatment option to ease patients' tense muscles and promote primary fascial closure. This study focus on how well preoperative botulinum toxin injections worked for patients with complicated abdominal wall hernias. Methodology: The patients in this retrospective study had complex abdominal wall hernias. Between January 2021 and December 2022, they had received preoperative botulinum toxin injections for those hernias. Age, gender, the extent of the transverse hernia defects both before and after the procedure, loss of domain, and muscle length, all were the study's variables. The data were analyzed using comparative analysis and paired t-tests. Results: The study involved 8 patients in all, with an average age of 53.38 ± 12.56 years. The mean fascial defect size before injection was 13.14 ± 4.58 cm, while the mean fascial defect size after injection was 11.84 ± 4.07 cm. Following the Botox injection, there was a statistically significant decrease in the size of the transverse hernia defect (p 0.001). The mean loss of domain before the surgery was 18.46 ± 11.96%, while the mean loss of domain after the 7.21%. Following the Botox injection, there was a statistically significant decrease in loss of domain (p 0.05). In 7 individuals, primary fascial closure was accomplished (87.5%). Both surgical and chemical components had no significant side effects. Conclusion: In individuals with complicated abdominal wall hernias, preoperative botulinum toxin injection is an efficient and secure method for lowering muscle tension and attaining primary fascial closure. it is challenging to make firm judgments on the effectiveness of preoperative Botox injection for complex abdominal wall hernia repair in the absence of a control group. The results of the current study need to be confirmed by larger studies with longer follow-up times and a control group.

show abstract

Incisional hernia repair with plication and utilization of Botox injections: First case report from Saudi Arabia for a 19‐year‐old female

Cited by 3 publications

References 22 publications

Ultrasound‐Guided Lateral Abdominal Wall Botulinum Toxin Injection Before Ventral Hernia Repair

Ultrasound‐Guided Lateral Abdominal Wall Botulinum Toxin Injection Before Ventral Hernia Repair

Is there a role for botulinum toxin A in the emergency setting for delayed abdominal wall closure in the management of the open abdomen? A systematic review

Preoperative Botulinum Toxin Injection for Complex Abdominal Wall Hernia Repair

Contact Info

Product

Resources

About